T2TRANSCRIPTIONAL RISK SCORE (TRS) FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Authors :: V. Richarte
María Soler Artigas
Paula Rovira
Cristina Sánchez-Mora
Marta Ribasés
Laia Benitez
Josep Antoni Ramos-Quiroga
Source :: European Neuropsychopharmacology. 29:S221
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pharmacology
medicine.medical_specialty
Framingham Risk Score
business.industry
medicine.disease
Psychiatry and Mental health
Neurology
medicine
Attention deficit hyperactivity disorder
Pharmacology (medical)
Neurology (clinical)
Psychiatry
business
Biological Psychiatry

Full Text Access

Tools